Jenna Ortega Box Office Report Card (1980–2026): Analyzing Every Movie Verdict

From Scream Queen to Beetlejuice: A Complete Trade Analysis of Jenna Ortega’s Career Box Office and 2026 Outlook

LOS ANGELES — The “Wednesday” halo is real, but the theatrical transition is harder than a viral TikTok dance.

As of April 2026, Jenna Ortega’s career box office haul as a leading or co-leading force has officially vaulted past the $900 million mark, largely driven by her status as the definitive Gen-Z scream queen and her recent transition into the $450 million club with Michael Keaton.

However, the trade reality in 2026 is a bit more nuanced than a simple upward arrow.

While she has anchored some of the most profitable horror revivals in the last decade, her recent forays into psychological thrillers and indie dramas have hit a significant speed bump.

We are looking at a star who can pull a massive opening weekend for a brand-name franchise, but the jury is still out on whether she can carry an original, mid-budget IP to profitability on her name alone.

The Analysis: The Franchise Anchor and the Gen-Z Multiplier

When we talk about Ortega’s trade value, we have to start with the “Woodsboro” effect.

In early 2022, Scream (the fifth installment) was the litmus test for whether legacy horror could survive the post-pandemic slump. It didn’t just survive; it thrived, becoming the 28th-highest-grossing film of the year. But the real trade story was Scream VI in 2023. That film was the definitive proof of the “Ortega Multiplier.”

Coming off the record-breaking success of her Netflix series, Ortega brought a massive wave of new Gen-Z fans to the theaters. The film saw a decent jump in its opening weekend compared to its predecessor, proving that her presence was worth millions in free social media marketing.

The studio logic was validated again in September 2024. Beetlejuice hit the trade boards like a freight train. It opened to a staggering $111 million, registering the second-biggest opening ever for the month of September.

While Michael Keaton and Tim Burton provided the nostalgia, Ortega provided the bridge to the youth demographic.

Roughly 73% of the total weekend box office earnings for that debut came from the film alone. By the end of its theatrical run, it had grossed $452 million worldwide. For Ortega, this was the ultimate trade victory—it moved her from the “niche horror” category into the “global blockbuster lead” conversation.

The Reality Check: The Indie Slump and Streaming Redemptions

But here is the catch. The industry doesn’t just look at the high-water marks; they look at the dips. As we stand here in April 2026, the discussion around Ortega has shifted toward her “filler work.” Since her Beetlejuice peak, she has been involved in several smaller projects that haven’t quite found their footing in a traditional theatrical window.

Are audiences only interested in Jenna Ortega when she’s wearing a Ghostface mask or gothic makeup?

Think about the 2025 release, Hurry Up Tomorrow. This psychological thriller, which paired her with Abel “The Weeknd” Tesfaye, was a certified box office disappointment. Produced on a $15 million budget, it only managed to scrape together $7.8 million at the worldwide box office by the end of its run.

The critical reception was equally brutal, sitting at a lowly 14% on the Tomatometer.

While the film is currently finding a second life on streaming—ranking #4 on STARZ this month—the theatrical run was a reality check for the “Ortega can sell anything” narrative.

Similarly, Death of a Unicorn was a modest performer. It cost $15 million and made about $20 million back, which is essentially a break-even scenario once you factor in P&A and the theater’s cut.

This is the classic trade dilemma. In a franchise, she is a force multiplier. In an original indie, she is still fighting for a per-theater average that matches her social media reach.

Breaking Down the Numbers and Historical Verticals

To see the full picture, you have to look at the Friday-to-Sunday dynamics of her major hits.

• Beetlejuice Beetlejuice (2024): The opening day was a monster, raking in $42 million, including $13 million from Thursday previews. The film showed incredible resilience, dropping only 54% in its second weekend and a slim 49% in its third, beating out massive newcomers like Speak No Evil and Transformers One.
• Scream VI (2023): This film proved that Ortega could sustain a franchise’s relevance. Early US trade numbers suggested that without her and Melissa Barrera, the series would lose its core Gen-Z audience. We are seeing that play out now in 2026 with Scream 7, which is maintaining a decent hold but has seen its buzz drop off significantly compared to the “Core Four” era.
• The Horror Indie Tier: Films like X (2022) were critical darlings but modest earners. X remains her best-reviewed film with a 94% score, though its worldwide total of roughly $15 million proves it was a cult hit rather than a broad commercial success.

The Taika Waititi Factor

Here is my take. Jenna Ortega is at a crossroads. She has conquered the franchise world, but her “star power” is currently in a state of flux. The $7.8 million disappointment of Hurry Up Tomorrow was a warning shot, but the industry is currently holding its breath for October 23, 2026.

That is when her next high-profile sci-fi drama, Klara and the Sun, directed by Taika Waititi, hits theaters.

With a first trailer that just dropped this month (April 2026), the buzz is astronomical. Sony is positioning this as a major awards contender, and if Ortega can deliver a commercial success in a prestige sci-fi drama, her trade value will become untouchable.

For now, her lifetime domestic collection is looking healthy, but she needs a non-horror hit to solidify her as the new box office queen.

Is she the next Julia Roberts, or is she the new queen of the mid-budget horror ghetto? We’ll know by Christmas.

With Scream 7 currently struggling to replicate the social media hype of Scream VI, do you think the franchise made a fatal trade error by letting Ortega go, or was her “star power” always tied to the Wednesday hype cycle?

Let’s break it down in the comments!

Nitesh Mishra, Box Office Analyst